All results

1 results

• INHALE

  INHALE-1 is a Phase 3, open-label, randomized clinical study evaluating the efficacy and safety of Afrezza in combination with a basal insulin (i.e., the…

  Ages

  4 Years - 17 Years

  Sexes

  All